Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.

Por Alok Pant, Irene I Lee, Zhenxiao Lu, Bo R Rueda, Julian Schink, J Julie Kim
Publicado em 2012-01-01

MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma

Por Eden R. Cardozo, Rosemary Foster, Anatte E. Karmon, Amy E. Lee, Leah W. Gatune, Bo R. Rueda, Aaron K. Styer
Publicado em 2018-05-01

Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.

Por Christopher K McCann, Whitfield B Growdon, Kashmira Kulkarni-Datar, Michael D Curley, Anne M Friel, Jennifer L Proctor, Hana Sheikh, Igor Deyneko, Jeanne A Ferguson, Vinod Vathipadiekal, Michael J Birrer, Darrell R Borger, Gayatry Mohapatra, Lawrence R Zukerberg, Rosemary Foster, John R Macdougall, Bo R Rueda
Publicado em 2011-01-01